Human papillomavirus oropharynx carcinoma: Aggressive de-escalation of adjuvant therapy.
Eric J MooreKathryn M Van AbelDavid M RoutmanChristine M LohseKatharine A R PriceMichelle Neben-WittichAshish V ChintakuntlawarDaniel L PriceJan L KasperbauerJoaquin J GarciaMichael L HinniSamir H PatelJeffrey R JanusRobert L FooteDan J MaPublished in: Head & neck (2020)
Patients with HPV(+)OPSCC who undergo surgical resection and neck dissection and meet criteria for adjuvant therapy can undergo aggressive dose de-escalation of RT without increasing risk of progression locally, regionally or at distant sites.